Safety and Target Engagement of Complement C1q Inhibitor ANX007 in Neurodegenerative Eye Disease by Yang Sun, MD, PhD, David Wirta, MD, Wendy Murahashi, MD, Vidhu Mathur, PhD, Sethu Sankaranarayanan, PhD, Lori K. Taylor, PhD, Ted Yednock, PhD, Donald S. Fong, MD, MPH, Jeffrey L. Goldberg, MD, PhD

Get full text